Safety of rituximab in rheumatoid arthritis
Patients with rheumatoid arthritis (RA) are at increased risk of manifestations such as serious infectious events (SIEs), malignancies and cardiovascular disease (1). Moreover, a long administration of drugs is required in this chronic disease, a condition that is responsible of a greater risk of si...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
PAGEPress Publications
2011-06-01
|
| סדרה: | Reumatismo |
| גישה מקוונת: | http://www.reumatismo.org/index.php/reuma/article/view/470 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|